Filing Details

Accession Number:
0001261380-13-000036
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-06-13 16:43:35
Reporting Period:
2013-06-11
Filing Date:
2013-06-13
Accepted Time:
2013-06-13 16:43:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1006045 Iridex Corp IRIX Electromedical & Electrotherapeutic Apparatus (3845) 770210467
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1234129 Eduardo Arias 1212 Terra Bella Avenue
Mountain View CA 94043
Sr. Vp, Global Sales No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-06-11 400 $3.53 5,900 No 4 M Direct
Common Stock Disposition 2013-06-11 400 $5.63 5,500 No 4 S Direct
Comon Stock Acquisiton 2013-06-11 300 $4.74 12,900 No 4 M Direct
Common Stock Disposition 2013-06-11 300 $5.61 12,600 No 4 S Direct
Common Stock Acquisiton 2013-06-11 300 $5.08 9,800 No 4 M Direct
Common Stock Disposition 2013-06-11 300 $5.61 9,500 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Right to Buy Disposition 2013-06-11 400 $0.00 400 $3.53
Common Stock Stock Option Right to Buy Disposition 2013-06-11 300 $0.00 300 $4.74
Common Stock Stock Option Right to Buy Disposition 2013-06-11 300 $0.00 300 $5.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,500 2008-03-13 2015-02-13 No 4 M Direct
12,600 2003-10-23 2013-09-23 No 4 M Direct
9,500 2005-04-30 2015-03-31 No 4 M Direct
Footnotes
  1. The sale reported in this Form 4 was pursuant to the Reporting Person's Rule 10b5-1 Selling Plan that was effective March 7, 2013.
  2. This option was granted pursuant to IRIDEX Corporation's incentive 1998 Stock Plan and is exempt pursuant to Rule 16b-3.
  3. The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest each month.